BMEZ
BlackRock Health Sciences Term Trust
1W: -1.9%
1M: -1.6%
3M: +6.0%
YTD: +11.3%
1Y: +14.5%
3Y: +47.2%
5Y: -5.6%
$16.47
-0.11 (-0.66%)
Weekly Expected Move ±2.3%
$16
$16
$16
$17
$17
ETF-Level Metrics
AUM$1.7B
Holdings133
Top 10 Wt24.0%
Beta0.85
% Profitable30%
Coverage78%
Portfolio Valuation
P/E21.8
P/B2.7
P/S2.7
EV/EBITDA18.5
P/FCF21.4
PEG4.69
Profitability & Returns
Gross Margin69.2%
Net Margin10.8%
ROE11.0%
ROA5.0%
ROIC10.9%
Div Yield0.94%
Leverage & Liquidity
Debt/Equity0.57
Debt/Assets0.25
Net Debt/EBITDA1.2x
Interest Cov10.5x
Current Ratio1.69
Quick Ratio1.23
Growth (YoY)
Revenue+18.1%
Net Income+0.2%
EPS+3.6%
FCF+16.4%
EBITDA+11.6%
Rev CAGR 3Y+20.8%
Quality Scores
Piotroski F5.0
Altman Z18.46
IS Quality64.1
IS Overall52.8
IS Value37.5
Median P/E-4.5
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 131 | 78.9% | -11.6 |
| Other | 43 | 21.1% | — |
| Financial Services | 2 | 1.3% | -0.0 |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| PODD | Insulet Corp. | 0.45% | 4 | Bullish | 2 | 2 | -11.1% |
Showing 50 of 176 holdings
· Page 1 of 4
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock Liquidity Funds Private | — | 4.81% | $48.7M | 48,671,382 | — | — | — |
| 2 | Johnson & Johnson | JNJ.SW | 3.52% | $35.6M | 145,639 | 29.6 | $535.1B | Healthcare |
| 3 | Merck & Co Inc | 6MK.DE | 3.12% | $31.6M | 262,388 | 114.5 | $314.9B | Healthcare |
| 4 | Gilead Sciences Inc | GILD.SW | 2.96% | $29.9M | 214,745 | -55.7 | $143.2B | Healthcare |
| 5 | Moderna Inc | 0QF.F | 2.76% | $27.9M | 549,814 | -23.8 | $66.4B | Healthcare |
| 6 | Biogen Inc | BIIB.SW | 2.49% | $25.2M | 137,487 | 30.0 | $20.8B | Healthcare |
| 7 | PsiQuantum Corp Private | — | 2.34% | $23.7M | 571,947 | — | — | — |
| 8 | Edwards Lifesciences Corp | EW | 2.20% | $22.3M | 277,879 | 48.9 | $49.0B | Healthcare |
| 9 | Guardant Health Inc | GH | 2.02% | $20.4M | 221,348 | -50.9 | $23.9B | Healthcare |
| 10 | Roche Holding AG | ROP.SW | 1.69% | $13.7M | 42,839 | 22.5 | $275.2B | Healthcare |
| 11 | Natera Inc | NTRA | 1.64% | $16.6M | 82,862 | -301.7 | $58.8B | Healthcare |
| 12 | Novartis AG | NOVN.SW | 1.58% | $12.8M | 104,397 | 21.3 | $221.1B | Healthcare |
| 13 | Amgen Inc | 4332.HK | 1.57% | $15.9M | 45,282 | — | $998.5B | Healthcare |
| 14 | Genmab A/S | GNMSF | 1.55% | $101.3M | 58,159 | 26.5 | $21.8B | Healthcare |
| 15 | Pfizer Inc | PFE.DE | 1.49% | $15.1M | 538,786 | 36.7 | $140.3B | Healthcare |
| 16 | Lonza Group AG | 0QNO.L | 1.47% | $11.9M | 23,258 | -367.3 | $39.5B | Healthcare |
| 17 | GSK PLC | GLAXF | 1.42% | $10.9M | 521,765 | 14.8 | $91.2B | Healthcare |
| 18 | Illumina Inc | ILU.DE | 1.42% | $14.3M | 116,338 | 25.9 | $18.8B | Healthcare |
| 19 | UCB SA | UCB.BR | 1.32% | $11.5M | 44,287 | 17.7 | $38.9B | Healthcare |
| 20 | RENAGADE THERAPEUTICS A 2 Private | — | 1.29% | $13.0M | 3,584,906 | — | — | — |
| 21 | AbbVie Inc | 4AB.DE | 1.28% | $13.0M | 59,784 | 74.0 | $408.1B | Healthcare |
| 22 | Agilent Technologies Inc | 0HAV.L | 1.27% | $12.8M | 112,566 | 33.0 | $53.3B | Healthcare |
| 23 | Sartorius AG | SUVPF | 1.17% | $10.2M | 47,229 | 88.8 | $19.1B | Healthcare |
| 24 | AstraZeneca PLC | ZEG.DE | 1.13% | $11.4M | 57,869 | 23.4 | $249.2B | Healthcare |
| 25 | ADARX PHARMACEUTICALS INC Private | — | 1.11% | $11.3M | 860,577 | — | — | — |
| 26 | BlackRock Funds III Private | — | 1.10% | $11.1M | 11,103,934 | — | — | — |
| 27 | Dexcom Inc | DXCM | 1.07% | $10.9M | 173,259 | 33.0 | $32.2B | Healthcare |
| 28 | Intuitive Surgical Inc | 0R29.L | 1.07% | $10.9M | 23,573 | 44.3 | $140.2B | Healthcare |
| 29 | Bristol-Myers Squibb Co | BMY.SW | 1.07% | $10.8M | 177,819 | 13.5 | $87.7B | Healthcare |
| 30 | Charles River Laboratories International Inc | CRL | 1.04% | $10.5M | 60,883 | -60.0 | $14.0B | Healthcare |
| 31 | Neurocrine Biosciences Inc | 0K6R.L | 1.04% | $10.5M | 79,676 | 20.3 | $14.3B | Healthcare |
| 32 | Hologic Inc | HLOI | 1.02% | $10.4M | 137,197 | — | — | Financial Services |
| 33 | Bridgebio Pharma Inc | BBIO | 1.00% | $10.2M | 136,783 | -18.8 | $13.2B | Healthcare |
| 34 | Danaher Corp | DAP.DE | 1.00% | $10.1M | 53,519 | 37.9 | $134.5B | Healthcare |
| 35 | Medtronic PLC | 2M6.DE | 0.99% | $10.0M | 115,270 | 21.1 | $98.6B | Healthcare |
| 36 | Immunocore Limited Private | — | 0.96% | $9.7M | 321,900 | — | — | — |
| 37 | Rhythm Pharmaceuticals Inc | RYTM | 0.96% | $9.7M | 111,452 | -29.8 | $6.4B | Healthcare |
| 38 | Boston Scientific Corp | BSX.F | 0.96% | $9.7M | 154,391 | 17.2 | $55.9B | Healthcare |
| 39 | Eisai Co Ltd | ESALF | 0.94% | $1.5B | 304,900 | 31.3 | $8.6B | Healthcare |
| 40 | Vertex Pharmaceuticals Inc | VX1.DE | 0.92% | $9.3M | 20,900 | 29.1 | $113.3B | Healthcare |
| 41 | LARONDE INC Private | — | 0.92% | $9.3M | 482,077 | — | — | — |
| 42 | Exelixis Inc | EX9.DE | 0.89% | $9.0M | 210,176 | 17.7 | $9.2B | Healthcare |
| 43 | Bio-Techne Corp | TECH | 0.88% | $8.9M | 169,594 | 61.9 | $11.3B | Healthcare |
| 44 | Argenx SE | ARGNF | 0.86% | $8.7M | 11,933 | 33.3 | $58.2B | Healthcare |
| 45 | Terns Pharmaceuticals Inc | TERN | 0.81% | $8.2M | 155,371 | -51.4 | $4.8B | Healthcare |
| 46 | NUMAB THERAPEUTICS AG Private | — | 0.80% | $6.5M | 1,139,305 | — | — | — |
| 47 | IQVIA Holdings Inc | 0JDM.L | 0.79% | $8.0M | 46,747 | 31.8 | $43.5B | Healthcare |
| 48 | KARTOS THERAPEUTICS INC Private | — | 0.75% | $7.6M | 1,333,783 | — | — | — |
| 49 | GENESIS THERAPEUTICS INC Private | — | 0.74% | $7.5M | 1,370,506 | — | — | — |
| 50 | Protagonist Therapeutics Inc | PTGX | 0.72% | $7.3M | 68,855 | 115.0 | $9.0B | Healthcare |